LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NYSE:ABX formerly NASDAQ: ABL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Abacus is the subject of a report issued by Mo ...

Core Viewpoint - Abacus Global Management, Inc. is making strategic moves to enhance shareholder value, including a transition of its stock listing from Nasdaq to NYSE and an increase in price target by Piper Sandler, indicating potential growth for investors [1][2][5]. Group 1: Stock Performance and Ratings - Piper Sandler maintains an "Overweight" rating for Abacus Global Management, raising the price target from $9 to $11, while the current stock price is $8.50, suggesting potential growth [1][5]. - The current stock price of ABL is $8.49, reflecting a slight decrease of 0.18% with a change of $0.015, and has fluctuated between $8.38 and $8.7 today [4]. Group 2: Stock Listing Transition - Abacus is transitioning its Class A common stock listing from Nasdaq to the New York Stock Exchange (NYSE), with trading expected to start on December 30, 2025, under the new ticker "ABX" [2][5]. - The company's 9.875% Fixed Rate Senior Notes will also move to the NYSE, expected to trade under the symbol "ABXL" starting December 30, 2025, as part of a broader strategy to increase market presence [3][5]. Group 3: Market Capitalization and Trading Volume - Abacus Global Management has a market capitalization of approximately $830.41 million and a trading volume of 436,740 shares on Nasdaq [4]. - Over the past year, ABL has seen a high of $9.61 and a low of $4.6, indicating significant volatility in its stock performance [4].

Core Viewpoint - Abacus Global Management, Inc. is transferring its listing from Nasdaq to the New York Stock Exchange, which is expected to enhance shareholder value and leverage the NYSE's advantages for growth [1][3]. Group 1: Listing Transfer Details - The transfer of Abacus' Class A common stock to the NYSE is anticipated to begin trading on or about December 30, 2025, under the new ticker symbol "ABX" [1]. - The Company's 9.875% Fixed Rate Senior Notes due 2028 will also transfer to the NYSE, starting to trade under the new ticker symbol "ABXL" on or about December 30, 2025 [2]. Group 2: Strategic Rationale - The decision to move to the NYSE is described as a strategic move aimed at creating long-term shareholder value, supported by the NYSE's global reach, strong institutional investor base, and deep market liquidity [3]. - The NYSE platform is expected to provide an exceptional foundation for Abacus' continued growth and innovation in the alternative asset management space [3]. Group 3: Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services, focusing on longevity-based assets and personalized financial planning [4].

Summary of Abacus Global Management Conference Call Company Overview - **Company Name**: Abacus Global Management (NasdaqCM: ABL) - **Industry**: Asset Management focused on life insurance assets - **History**: Over 20 years of operation, public for 10 quarters Key Financial Metrics - **Q1 Revenue Growth**: Year-over-year growth of over 100% in revenue [4] - **Adjusted Net Income Guidance**: Targeting approximately 80% year-over-year growth [4] - **EBITDA Margin**: Greater than 60% [4] - **Return on Equity (ROE) and Return on Invested Capital (ROIC)**: Both over 20% [4] - **Dividend Yield**: Over 2.5% with the first annual dividend announced [6] - **Market Valuation**: Trading at a multiple of approximately 2.5 earnings, with expectations for growth [5] Business Model and Strategy - **Core Business**: Abacus operates as both an origination company and an asset manager, controlling the lifecycle of client assets [3] - **Market Opportunity**: Positioned in a $14 trillion life insurance industry, with a focus on acquiring life insurance policies as assets [7][10] - **Recurring Revenue**: Aiming to increase recurring revenue from 15% to 70% over the next three to five years [15] - **Growth Strategy**: Plans to triple revenue over the last two years and double it again in the next three years [16] Unique Selling Proposition - **Regulatory Advantage**: Licensed in every state to operate in a highly regulated market [10] - **Data Utilization**: Developed technology to track mortality with 99% accuracy within 48 hours, significantly outperforming traditional systems [18] - **Asset Characteristics**: Life insurance policies are typically A-rated, cash-reserved, and uncorrelated to market fluctuations [12][13] Growth Areas - **Asset Management**: Currently managing approximately $3-$3.5 billion in assets under management (AUM), with expectations to reach $10 billion in five years [26] - **Technology Division**: Significant growth in tracking lives for mortality data, expanding from 26,000 to 2.6 million lives monitored [29] - **Wealth Advisory Services**: Developing financial solutions based on lifespan data to assist clients in retirement planning [19] Market Position and Future Outlook - **Market Penetration**: Abacus is a dominant player in an underpenetrated market, with a unique position as the only public company in its industry with recurring revenue [7] - **Securitization Plans**: Launched its first securitization in October, with plans for more in 2026 to optimize capital costs [32] - **Investor Engagement**: Committed to educating investors about the business model and growth potential [36] Conclusion - **Investment Opportunity**: Abacus presents a compelling investment opportunity with strong growth metrics, a unique business model, and a significant market opportunity in the life insurance asset management space [36]

Core Insights - Abacus Global Management, Inc. (NASDAQ: ABL) is recognized as one of the best life insurance stocks to invest in currently [1] - Northland Securities analyst Michael Grondahl maintains a bullish outlook on Abacus Life, Inc., reaffirming a buy rating with a price target of $13.50 [2] - The company announced its first-ever annual cash dividend of $0.20 per share, set to be paid on December 17, 2025, to shareholders of record as of December 2, 2025 [3] Financial Performance - For Q3, Abacus Global Management reported non-GAAP earnings per share of $0.24, exceeding projections by $0.06, with revenue of $63 million surpassing expectations by $15.58 million, reflecting a year-on-year revenue increase of 124.2% [5] - The company's dividend policy allows for payouts of up to 25% of adjusted net income or 55% of recurring revenue, supported by record cash creation, higher fee-based revenue, and growing margins [4] Business Focus - Abacus Global Management specializes in institutional services, life solutions, data-driven wealth solutions, and alternative asset management [6]

Industry Overview - Fitch Ratings maintains a 'neutral' outlook for the North American life insurance sector in 2026, citing solid balance sheets as a partial offset to slower economic growth and increased macroeconomic volatility [2][4] - Life insurers are expected to maintain strong capitalization and careful asset-liability management despite higher exposure to private credit, with investment risk likely to rise slightly [2][4] - The regulatory environment is dynamic, focusing on capital adequacy relative to risk, with strong capitalization mitigating market susceptibility [3] Financial Performance - Operating profits are projected to remain unchanged, with spread widening expected to increase net investment income, although policy rate cuts may slightly offset this benefit [4] - Primerica, Inc. reported adjusted net operating income of $206 million for Q3 2025, up 7% year over year, with EPS increasing by 11% to $6.33 [16] - Abacus Global Management, Inc. reported Q3 non-GAAP earnings per share of $0.24, exceeding projections by $0.06, and revenue of $63 million, which was $15.58 million above expectations, reflecting a 124.2% year-on-year increase [12] Investment Opportunities - The article lists the 9 Best Life Insurance Stocks to Buy Now, focusing on stocks with strong hedge fund holdings and potential upside [5][7] - Abacus Global Management, Inc. has a significant upside potential of 98.13% as of December 4, 2025, with a buy rating reaffirmed by analysts [9] - Primerica, Inc. has a potential upside of 19.97%, with a consensus 1-year median price target of $303, despite a cautious outlook from analysts [14]

Group 1 - U.S. stock futures are higher, with Dow futures gaining around 50 points [1] - Tilray Brands Inc announced a one-for-10 reverse stock split, effective December 1 [1] - Tilray shares fell sharply by 15% to $0.88 in pre-market trading [2] Group 2 - Inventiva ADR fell 7.4% to $4.26 in pre-market trading after a previous gain [4] - Anglogold Ashanti PLC dipped 5.5% to $83.97 in pre-market trading after a gain of over 5% [4] - Lexicon Pharmaceuticals Inc fell 5% to $1.36 in pre-market trading [4] - SuperX AI Technology Ltd fell 3.9% to $26.00 in pre-market trading after a significant previous jump of 23% [4] - Palisade Bio Inc declined 3.6% to $2.15 in pre-market trading [4] - Gold Fields Ltd fell 3.4% to $41.76 in pre-market trading after a gain of 6% [4] - Abacus Global Management Inc fell 3.2% to $6.33 in pre-market trading after reporting better-than-expected third-quarter results and announcing a $10 million buyback [4]

Core Viewpoint - Abacus Life, Inc. (ABL) shows significant upside potential with a mean price target of $13.1, indicating an 110.3% increase from its current trading price of $6.23 [1] Price Targets and Analyst Consensus - The average price target for ABL ranges from a low of $9.00 to a high of $15.00, with a standard deviation of $2.36, suggesting a variability in estimates [2] - The lowest estimate indicates a potential increase of 44.5%, while the highest suggests a 140.8% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism about ABL's earnings prospects, as indicated by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has increased by 4.8% over the past month, with three estimates revised upward and no negative revisions [12] - ABL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][7] - Price targets should be treated with skepticism, as they can mislead investors more often than guide them [10]

Core Viewpoint - Abacus Global Management has announced its inaugural annual cash dividend of $0.20 per share, reflecting confidence in its business sustainability and a commitment to shareholder returns [2][3]. Dividend Announcement - The annual cash dividend of $0.20 per share will be payable on December 17, 2025, to shareholders of record as of December 2, 2025 [2]. - This dividend represents a distribution of up to 25% of adjusted net income or up to 55% of recurring revenue, as per the company's capital allocation framework [2]. Management Commentary - The introduction of an annual dividend is seen as a significant milestone for the company, indicating strong cash generation and growing fee-based revenues [3]. - The dividend will be funded through cash on hand and free cash flow, supporting the company's disciplined capital allocation strategy [3]. Dividend Policy - Abacus has adopted a dividend policy aimed at balancing consistent shareholder returns with strategic growth investments [7]. - The Board of Directors will evaluate opportunities for capital return through dividends based on factors such as operating cash flow, capital requirements, and strategic investment opportunities [8]. Flexibility in Dividend Declarations - The policy allows the Board to declare dividends while maintaining adequate liquidity for portfolio origination and business expansion [9]. - Specific dividend declarations will remain at the Board's discretion, influenced by business conditions [9]. Company Overview - Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, and technology innovations [10]. - The company focuses on longevity-based assets and personalized financial planning, leveraging proprietary data analytics and industry expertise [10].

Core Viewpoint - Abacus Global Management has reported its tenth consecutive quarter of earnings, showcasing consistent performance and growth in funding and origination capabilities, with a strong outlook into 2026 [1][2]. Financial Performance - Gross revenue increased by 124% year-over-year, while adjusted net income grew by 60% [2]. - The company has achieved earnings beats greater than 30% in six of the last ten quarters, indicating sustained performance [2]. Business Model and Strategy - Abacus operates as an active management company, monetizing contracts and policies on its balance sheet with strong margins of around 37% [3]. - The company has raised nearly $500 million in new capital this year, driven by strong institutional interest in uncorrelated yield [3]. Revenue Composition - 15% of Abacus's revenue is now recurring, and the recently launched dividend represents just over 20% of adjusted net income, allowing for capital return to shareholders while maintaining a return on equity (ROE) over 20% [4]. Recent Acquisitions - The acquisition of AccuQuote enhances client lifecycle coverage, enabling the company to offer better-suited policies and convert previously unmonetized leads into product sales [5][6]. - AccuQuote brings 30 years of experience and $150 million in issued premium, providing both new policy sales and potential legacy contract value [6]. Securitization and Balance Sheet Strength - A recent $50 million securitized asset transaction strengthens the balance sheet and supports future growth through scalable and competitive rates [7][8]. - The participation of insurance companies and banks in this transaction validates the valuations and underlying assets, while the company earns servicing fees for five years [8]. Market Position and Investor Appeal - Being added to the Russell 2000 and 3000 indexes enhances Abacus's visibility, attracting more capital from ETFs and investors seeking strong companies [9]. - The company is now a dividend-paying stock with a yield between 3.5% and 4.5%, placing it in a selective group among Russell 2000 companies [10].